Sign inJoin waitlistJoin the waitlist

Edmund Waller

Medical Director, Center for Stem Cell Processing and Apheresis · Winship Cancer Institute at Emory Midtown

Credentials: · · · · · ·

History

Center for Stem Cell Processing and Apheresis · Winship Cancer Institute at Emory Midtown
Present
Center for Regenerative Engineering and Medicine · Winship Cancer Institute at Emory Midtown
Present
Bone Marrow and Stem Cell Transplant Center · Morehouse School of Medicine
Present

Medical Oncology
1989–1991
Internal Medicine
Stanford Health Care
1985–1986
Rockefeller University in New York, New York
Cornell Univ Joan and Sanford I Weill Med Coll
1981–1985
Harvard University

Research

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2019 · 3,379 citations
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
Blood · 1997 · 794 citations
Peripheral-blood stem cells versus bone marrow from unrelated donors
New England Journal of Medicine · 2012 · 722 citations

Amelia Langston
49 papers
Sagar Lonial
46 papers · 5 as a fellow
Arshed Quyyumi
37 papers
Christopher Flowers
37 papers
Daniel Weisdorf
33 papers
Hillard Lazarus
33 papers
BS
Bipin Savani
28 papers
Mark Litzow
24 papers
HK
Hanna Khoury
23 papers
Richard Maziarz
23 papers
Joseph McGuirk
22 papers
David Jaye
20 papers · 2 as a fellow

Grants

BMT Core: Southeast Bone Marrow Transplant Consortium
National Heart, Lung, and Blood Institute · UG1
Contact PI · $712.8K · Emory University
2024–2031
Targeting VIP–VPAC Signaling to Reverse Immune Exclusion and Enhance Immunotherapy Response in Pancreatic Cancer
National Cancer Institute · R01
Contact PI · $636.4K · Emory University
2026–2031
Leveraging CD26high Meso-CAR T Cells in Patients with Advanced Pancreatic Cancer
National Cancer Institute · R01
PI · $1.9M · Emory University
2024–2029
Targeting Androgen-Driven Resistance to Immune Checkpoint Inhibitors in Pancreatic Ductal Adenocarcinoma
National Cancer Institute · R21
Contact PI · $402.4K · Emory University
2026–2028

Clinical trials

Bone Marrow and Peripheral Blood Immune Responses Study
Principal investigator · Recruiting · Phase 4
Emory University
2023–2029
Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study
Principal investigator · Completed · Early phase 1
Emory University
2022–2024
Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
Principal investigator · Completed · Phase 2
Emory University
2020–2021
A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin
Principal investigator · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2020–2022